| Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis R Pinyol, S Torrecilla, H Wang, C Montironi, M Piqué-Gili, M Torres-Martin, ... Journal of hepatology 75 (4), 865-878, 2021 | 155 | 2021 |
| Early inhibition of hepatocyte innate responses by hepatitis B virus S Luangsay, M Gruffaz, N Isorce, B Testoni, M Michelet, S Faure-Dupuy, ... Journal of hepatology 63 (6), 1314-1322, 2015 | 155 | 2015 |
| Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection S Faure-Dupuy, M Delphin, L Aillot, L Dimier, F Lebossé, J Fresquet, ... Journal of hepatology 71 (6), 1086-1098, 2019 | 83 | 2019 |
| Characterization of the inflammasome in human kupffer cells in response to synthetic agonists and pathogens C Zannetti, G Roblot, E Charrier, M Ainouze, I Tout, F Briat, N Isorce, ... The Journal of Immunology 197 (1), 356-367, 2016 | 77 | 2016 |
| Interplay between the hepatitis B virus and innate immunity: from an understanding to the development of therapeutic concepts S Faure-Dupuy, J Lucifora, D Durantel Viruses 9 (5), 95, 2017 | 71 | 2017 |
| Characterization of pattern recognition receptor expression and functionality in liver primary cells and derived cell lines S Faure-Dupuy, S Vegna, L Aillot, L Dimier, K Esser, M Broxtermann, ... Journal of innate immunity 10 (4), 339-348, 2018 | 50 | 2018 |
| Liver macrophages: Friend or foe during hepatitis B infection? S Faure‐Dupuy, D Durantel, J Lucifora Liver international 38 (10), 1718-1729, 2018 | 29 | 2018 |
| A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control S Namineni, T O'Connor, S Faure-Dupuy, P Johansen, T Riedl, K Liu, ... Journal of hepatology 72 (5), 960-975, 2020 | 24 | 2020 |
| Hypoxia‐Inducible Factor 1 Alpha–Mediated RelB/APOBEC3B Down‐regulation Allows Hepatitis B Virus Persistence T Riedl, S Faure‐Dupuy, M Rolland, S Schuehle, Z Hizir, S Calderazzo, ... Hepatology 74 (4), 1766-1781, 2021 | 19 | 2021 |
| Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p S Faure-Dupuy, T Riedl, M Rolland, Z Hizir, F Reisinger, K Neuhaus, ... JHEP reports 3 (6), 100354, 2021 | 17 | 2021 |
| Inducers of the NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitro M Michelet, D Alfaiate, B Chardès, C Pons, S Faure-Dupuy, T Engleitner, ... JHEP reports 4 (3), 100415, 2022 | 9 | 2022 |
| Inhibitory effect of IL-1β on HBV and HDV replication and HBs antigen-dependent modulation of its secretion by macrophages M Delphin, S Faure-Dupuy, N Isorce, M Rivoire, A Salvetti, D Durantel, ... Viruses 14 (1), 65, 2021 | 9 | 2021 |
| Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activation O Colasanti, R Burm, HE Huang, T Riedl, J Traut, N Gillich, TF Li, ... Journal of Hepatology 79 (3), 645-656, 2023 | 8 | 2023 |
| Virus hijacking of host epigenetic machinery to impair immune response M Locatelli, S Faure-Dupuy Journal of Virology 97 (9), e00658-23, 2023 | 7 | 2023 |
| ARL5b inhibits human rhinovirus 16 propagation and impairs macrophage-mediated bacterial clearance S Faure-Dupuy, J Jubrail, M Depierre, K Africano-Gomez, L Öberg, ... EMBO reports 25 (3), 1156-1175, 2024 | 1 | 2024 |
| Targeting immuno-metabolism and anti-viral immune responses in chronic hepatitis B S Faure-Dupuy, TF Baumert Hepatology international 17 (5), 1075-1078, 2023 | 1 | 2023 |
| How to get away with liver innate immunity? A viruses’ tale M Delphin, M Desmares, S Schuehle, M Heikenwalder, D Durantel, ... Liver International 41 (11), 2547-2559, 2021 | 1 | 2021 |
| Régulation de l’immunopathogenèse du virus de l’hépatite B par des cellules myéloïdes suppressives S Faure-Dupuy, J Lucifora médecine/sciences 32 (3), 238-241, 2016 | 1 | 2016 |
| HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx M Ringelhan, S Schuehle, M van de Klundert, E Kotsiliti, ML Plissonnier, ... JHEP Reports, 101128, 2024 | | 2024 |
| Rôle de la petite GTPase ARL5b dans l’inhibition de la clairance bactérienne par le rhinovirus humain 16 Z Fremont-Debaene, S Faure-Dupuy médecine/sciences 40 (6-7), 492-494, 2024 | | 2024 |
